Chiu, M <br/><br/>
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts.  [electronic resource] 

 -  British journal of cancer  Sep 2014 
 - 1159-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-1827 
<br/><br/><label>Standard No.: </label>10.1038/bjc.2014.425  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Asparaginase--pharmacology<br/>Asparagine--blood<br/>Cadherins--analysis<br/>Carcinoma, Hepatocellular--drug therapy<br/>Enzyme Inhibitors--therapeutic use<br/>Glutamate-Ammonia Ligase--antagonists & inhibitors<br/>Glutamine--analysis<br/>Hep G2 Cells<br/>Humans<br/>Ki-67 Antigen--analysis<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Methionine Sulfoximine--therapeutic use<br/>Mice<br/>Mice, Nude<br/>Mutation<br/>Tumor Burden--drug effects<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--analysis